SOPHiA GENETICS revenue rises 25% to $24.3 million

Nov 3, 2026
SOPHiA GENETICS reported $24.3 million in third quarter revenue, while its adjusted EBITDA loss narrowed to $6.1 million.

SOPHiA GENETICS reported in its third quarter earnings release that revenue rose 25% from a year earlier to $24.3 million. Its net loss increased 1% to $20.3 million, while its adjusted EBITDA loss narrowed 31% to $6.1 million.

The company processed a record 118,000 analyses on its SOPHiA DDM platform, up 19% from the prior year. It ended the quarter with 551 core genomics customers and signed 30 new customers that it expects to begin generating revenue over the next 12 months.

SOPHiA GENETICS also signed a multimodal AI project to develop a predictor for identifying bladder cancer patients likely to benefit from a targeted therapy. It expects full year 2026 revenue to reach the upper end of its previous $94 million to $96 million guidance and forecasts an adjusted EBITDA loss of $29 million to $32 million.

We hope you enjoyed this article

Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Free newsletter

AI Funding Brief

Whitepaper

Tensordyne Napier: What If One Rack Could Do the Work of Nine?

Tensordyne

This Tensordyne whitepaper presents Napier, an inference-focused AI processor and rack-scale system based on the company’s TDN Math logarithmic number system. It examines infrastructure requirements for large mixture-of-experts and agentic models, compares major inference architecture approaches, and details the TDN AIP processor, TDN72 pod, TDN Link fabric, and Napier Ultra configuration. The paper reports simulation-based performance, cost, and accuracy-validation results, including Tensordyne’s projected comparison of one Napier rack with a nine-rack Nvidia Rubin plus Groq deployment; the chip is reported as taped out and in fabrication.

Read more
Free, six days a week

Daily AI Brief: the AI news that matters, in your inbox.